Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jun 01, 2009

Mylan's Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs

Jun 01, 2009

Mylan Announces Successful Matrix Delisting Offer

May 29, 2009

Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)

May 29, 2009

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

May 28, 2009

Mylan Names Jolene Varney Chief Financial Officer

May 07, 2009

Mylan Announces Change in Board Leadership

May 07, 2009

Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept(R)

Apr 30, 2009

Mylan Reports Adjusted Diluted EPS of $0.33 for the Quarter Ended March 31, 2009

Apr 30, 2009

Mylan Remains the Only Approved ANDA for All Strengths of Amlodipine Besylate Tablets

Apr 20, 2009

Mylan Schedules First Quarter 2009 Financial Results Conference Call and Live Webcast

Pagination

First page
Previous page
…
Page 85
Page 86
Page 87
Page 88
Current page 89
Page 90
Page 91
Page 92
Page 93
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.